Zhonghong Pulin Medical Products Co. Ltd. (300981) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.008x

Based on the latest financial reports, Zhonghong Pulin Medical Products Co. Ltd. (300981) has a cash flow conversion efficiency ratio of -0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-44.36 Million ≈ $-6.49 Million USD) by net assets (CN¥5.51 Billion ≈ $806.04 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300981 company net worth for the company's overall valuation and market capitalisation.

Zhonghong Pulin Medical Products Co. Ltd. - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Zhonghong Pulin Medical Products Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhonghong Pulin Medical Products Co. Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhonghong Pulin Medical Products Co. Ltd. ranked by their cash flow conversion efficiency. Explore Zhonghong Pulin Medical Products Co. Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
EFORT Intelligent Equipment Co Ltd
SHG:688165
-0.095x
Jaiprakash Power Ventures Limited
NSE:JPPOWER
0.082x
COMPUGROUP MED.SP.ADR 1
F:COPA
N/A
Chengdu Yunda Technology Co Ltd
SHE:300440
0.004x
Cansino Biologics Inc
SHG:688185
0.003x
Delong Composite Energy Group Co Ltd
SHE:000593
0.009x
Corbion NV
AS:CRBN
0.038x
Smartgroup Corporation Ltd
AU:SIQ
0.253x

Annual Cash Flow Conversion Efficiency for Zhonghong Pulin Medical Products Co. Ltd. (2013–2025)

The table below shows the annual cash flow conversion efficiency of Zhonghong Pulin Medical Products Co. Ltd. from 2013 to 2025. View Zhonghong Pulin Medical Products Co. Ltd (300981) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.42 Billion
≈ $793.36 Million
CN¥3.74 Million
≈ $546.65K
0.001x -97.89%
2024-12-31 CN¥5.62 Billion
≈ $822.48 Million
CN¥183.91 Million
≈ $26.91 Million
0.033x +37.58%
2023-12-31 CN¥5.92 Billion
≈ $865.55 Million
CN¥140.68 Million
≈ $20.59 Million
0.024x +36.68%
2022-12-31 CN¥6.13 Billion
≈ $897.39 Million
CN¥106.71 Million
≈ $15.61 Million
0.017x -95.17%
2021-12-31 CN¥6.55 Billion
≈ $959.08 Million
CN¥2.36 Billion
≈ $345.71 Million
0.360x -66.13%
2020-12-31 CN¥2.56 Billion
≈ $373.98 Million
CN¥2.72 Billion
≈ $397.97 Million
1.064x +169.91%
2019-12-31 CN¥467.67 Million
≈ $68.43 Million
CN¥184.38 Million
≈ $26.98 Million
0.394x +523.91%
2018-12-31 CN¥376.10 Million
≈ $55.03 Million
CN¥23.77 Million
≈ $3.48 Million
0.063x -78.95%
2017-12-31 CN¥319.89 Million
≈ $46.81 Million
CN¥96.03 Million
≈ $14.05 Million
0.300x -25.15%
2016-12-31 CN¥255.25 Million
≈ $37.35 Million
CN¥102.37 Million
≈ $14.98 Million
0.401x -16.73%
2015-12-31 CN¥191.49 Million
≈ $28.02 Million
CN¥92.23 Million
≈ $13.50 Million
0.482x -45.34%
2014-12-31 CN¥151.32 Million
≈ $22.14 Million
CN¥133.33 Million
≈ $19.51 Million
0.881x +727.53%
2013-12-31 CN¥125.53 Million
≈ $18.37 Million
CN¥13.37 Million
≈ $1.96 Million
0.106x --

About Zhonghong Pulin Medical Products Co. Ltd.

SHE:300981 China Medical Instruments & Supplies
Market Cap
$1.14 Billion
CN¥7.78 Billion CNY
Market Cap Rank
#8368 Global
#1958 in China
Share Price
CN¥18.15
Change (1 day)
+14.01%
52-Week Range
CN¥9.50 - CN¥18.15
All Time High
CN¥47.82
About

Zhonghong Pulin Medical Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable health protection products, sterile medical devices, and life support solutions in China and internationally. It operates through the Health Protection Products Division; Safe Infusion Products Division; and Innovation and Incubation Product Division… Read more